Jens Cosedis Nielsen.
In the rest of the 4 methods, the indications were ideal atrial flutter , atrioventricular nodal reentrant tachycardia , and focal atrial tachycardia . At two years, 13 sufferers in the ablation group had been receiving antiarrhythmic medication therapy. In the drug-therapy group, a total of 146 patients were treated with class IC antiarrhythmic drugs or class III antiarrhythmic drugs . The mean number of agents used through the scholarly study period was 1.46 . Supplementary radiofrequency ablation was performed in 54 patients , who underwent a mean of 1 1.7 ablation techniques, the 1st at a mean of 8.5 months after inclusion in the scholarly study.There have been no significant interactions among subgroups or according to the stratification variables: presence versus absence of H. Pylori and use versus nonuse of an NSAID . There is a borderline significant interaction on the basis of sex . Event rates for individual components of the composite gastrointestinal end stage are listed in Table 2Table 2Event Rates for Principal Composite End Factors and Their Individual Components at 180 Days after Randomization, According to review Treatment. Significant variations were seen between the omeprazole group and the placebo group with regard to overt gastroduodenal bleeding and overt higher gastrointestinal bleeding of unknown origin . The price of the composite end point of overall medical gastrointestinal bleeding was also reduced with omeprazole in comparison with placebo , as was the price of the composite end point of overt gastroduodenal bleeding or overt higher gastrointestinal bleeding of unknown origin: from 1.2 percent in the placebo group to 0.2 percent .